Kinnate Biopharma Inc. (KNTE)

NASDAQ: KNTE · Real-Time Price · USD

2.65

-0.01 (-0.38%)

At close: Apr 02, 2024, 8:00 PM

Kinnate Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-112.65M	-116.27M	-89.76M	-35.76M	-11.97M	-7.63M
Depreciation & Amortization	799K	604K	123K	83K	n/a	n/a
Stock-Based Compensation	19.92M	19.58M	15.02M	2.48M	39K	39K
Other Working Capital	1.37M	2.17M	-3.05M	-2.35M	-25K	-611K
Other Non-Cash Items	22.18M	682K	1.94M	5K	-1.39M	n/a
Deferred Income Tax	-26.59M	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-3.7M	6.37M	1.62M	3.01M	1.4M	-611K
Operating Cash Flow	-100.04M	-89.03M	-71.06M	-30.18M	-10.53M	-8.2M
Capital Expenditures	n/a	-2.72M	-769K	-297K	n/a	n/a
Cash Acquisitions	-9.13M	4.11K	34.85M	n/a	n/a	n/a
Purchase of Investments	-154.72M	-176.53M	-247.14M	-31.41M	n/a	n/a
Sales Maturities Of Investments	264.59M	172.42M	67.34M	n/a	n/a	n/a
Other Investing Acitivies	n/a	-4.11K	-34.85M	-31.41K	n/a	n/a
Investing Cash Flow	100.74M	-6.83M	-180.57M	-31.71M	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	-17K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-7.81M	1.16M	36.24M	350.9M	79.98M	15.2M
Financial Cash Flow	1.32M	1.16K	36.24K	350.9M	79.98M	15.2M
Net Cash Flow	2.01M	-94.7M	-215.4M	289.01M	69.45M	7M
Free Cash Flow	-100.04M	-91.75M	-71.83M	-30.48M	-10.53M	-8.2M